Hypothalamic Protein Kinase C Regulates Glucose Production

Hypothalamic Protein Kinase C Regulates Glucose Production Rachel Ross 1 , Penny Y.T. Wang 2 , Madhu Chari 2 3 , Carol K.L. Lam 2 3 , Liora Caspi 2 , Hiraku Ono 1 , Evan D. Muse 1 , Xiaosong Li 1 , Roger Gutierrez-Juarez 1 , Peter E. Light 4 , Gary J. Schwartz 1 , Luciano Rossetti 1 and Tony K.T. Lam 2 3 1 Departments of Molecular Pharmacology, Medicine, and Neuroscience, Albert Einstein College of Medicine, Bronx, New York 2 Toronto General Hospital Research Institute, University Health Network, Toronto, Canada 3 Departments of Physiology and Medicine, University of Toronto, Toronto, Canada 4 Department of Pharmacology, University of Alberta, Edmonton, Canada Corresponding author: Dr. Tony Lam, tony.lam{at}uhnres.utoronto.ca Abstract OBJECTIVE— A selective rise in hypothalamic lipid metabolism and the subsequent activation of SUR1/Kir6.2 ATP-sensitive K + (K ATP ) channels inhibit hepatic glucose production. The mechanisms that link the ability of hypothalamic lipid metabolism to the activation of K ATP channels remain unknown. RESEARCH DESIGN AND METHODS— To examine whether hypothalamic protein kinase C (PKC) mediates the ability of central nervous system lipids to activate K ATP channels and regulate glucose production in normal rodents, we first activated hypothalamic PKC in the absence or presence of K ATP channel inhibition. We then inhibited hypothalamic PKC in the presence of lipids. Tracer-dilution methodology in combination with the pancreatic clamp technique was used to assess the effect of hypothalamic administrations on glucose metabolism in vivo. RESULTS— We first reported that direct activation of hypothalamic PKC via direct hypothalamic delivery of PKC activator 1-oleoyl-2-acetyl-sn-glycerol (OAG) suppressed glucose production. Coadministration of hypothalamic PKC-δ inhibitor rottlerin with OAG prevented the ability of OAG to activate PKC-δ and lower glucose production. Furthermore, hypothalamic dominant-negative Kir6.2 expression or the delivery of the K ATP channel blocker glibenclamide abolished the glucose production-lowering effects of OAG. Finally, inhibition of hypothalamic PKC eliminated the ability of lipids to lower glucose production. CONCLUSIONS— These studies indicate that hypothalamic PKC activation is sufficient and necessary for lowering glucose production. Footnotes Published ahead of print at http://diabetes.diabetesjournals.org on 28 May 2008. Readers may use this article as long as the work is properly cited, the use is